Eva Rossmann

957 total citations
23 papers, 610 citations indexed

About

Eva Rossmann is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Eva Rossmann has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Genetics and 8 papers in Oncology. Recurrent topics in Eva Rossmann's work include Chronic Lymphocytic Leukemia Research (10 papers), Immunotherapy and Immune Responses (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Eva Rossmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Immunotherapy and Immune Responses (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Eva Rossmann collaborates with scholars based in Sweden, Switzerland and France. Eva Rossmann's co-authors include Håkan Mellstedt, Anders Österborg, Andréas Fink, Jeanette Lundin, Mahmood Jeddi‐Tehrani, Anders Österborg, Lotta Hansson, Rodiça Lenkei, Shahryar Kiaii and Aniruddha Choudhury and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Eva Rossmann

21 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Rossmann Sweden 12 343 201 171 131 127 23 610
Thomas Poiret Sweden 14 312 0.9× 327 1.6× 70 0.4× 113 0.9× 9 0.1× 30 656
Lalit Rane Sweden 11 205 0.6× 175 0.9× 71 0.4× 70 0.5× 14 0.1× 19 439
Julia Carnevale United States 14 258 0.8× 417 2.1× 50 0.3× 422 3.2× 111 0.9× 28 924
Christopher Allen United Kingdom 14 100 0.3× 102 0.5× 366 2.1× 579 4.4× 65 0.5× 36 1.4k
Shai Rosenberg Israel 13 37 0.1× 206 1.0× 142 0.8× 226 1.7× 78 0.6× 33 731
Tim Sauer Germany 17 326 1.0× 734 3.7× 52 0.3× 378 2.9× 45 0.4× 50 1.1k
Christine M. Coquery United States 10 357 1.0× 94 0.5× 35 0.2× 149 1.1× 27 0.2× 12 614
Svetlana M. Mazel United States 9 389 1.1× 160 0.8× 16 0.1× 264 2.0× 22 0.2× 10 637
Maria R. Fischette United States 11 328 1.0× 216 1.1× 14 0.1× 716 5.5× 61 0.5× 12 1.3k
Stefanie Schmidt Germany 8 319 0.9× 65 0.3× 46 0.3× 81 0.6× 59 0.5× 13 519

Countries citing papers authored by Eva Rossmann

Since Specialization
Citations

This map shows the geographic impact of Eva Rossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rossmann more than expected).

Fields of papers citing papers by Eva Rossmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Rossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rossmann. The network helps show where Eva Rossmann may publish in the future.

Co-authorship network of co-authors of Eva Rossmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Rossmann. A scholar is included among the top collaborators of Eva Rossmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Rossmann. Eva Rossmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dejardin, David, et al.. (2023). Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data. Journal for ImmunoTherapy of Cancer. 11(2). e006464–e006464. 20 indexed citations
3.
Ullenhag, Gustav, Eva Rossmann, & Maria Liljefors. (2015). A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer. PLoS ONE. 10(4). e0121197–e0121197. 7 indexed citations
4.
Rossmann, Eva, Anders Österborg, Eva Löfvenberg, et al.. (2014). Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study. Human Vaccines & Immunotherapeutics. 10(11). 3394–3408. 18 indexed citations
5.
Kiaii, Shahryar, Parviz Kokhaei, Fariba Mozaffari, et al.. (2012). T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile. Cancer Immunology Immunotherapy. 62(1). 51–63. 16 indexed citations
6.
Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Martin Norin, et al.. (2012). Phosphorylation of Receptor Tyrosine Kinase ROR1 At Tyrosine 641, 646 and Serine 652 residues Might Be of Importance for the Survival of CLL Leukemic Cells. Blood. 120(21). 3885–3885. 1 indexed citations
7.
Palma, Marzia, Lotta Hansson, Aniruddha Choudhury, et al.. (2011). Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunology Immunotherapy. 61(6). 865–879. 53 indexed citations
8.
Rossmann, Eva, Anders Österborg, Eva Löfvenberg, et al.. (2011). Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma. Blood. 118(21). 2927–2927. 1 indexed citations
9.
10.
Rossmann, Eva & Andréas Fink. (2010). Do creative people use shorter associative pathways?. Personality and Individual Differences. 49(8). 891–895. 74 indexed citations
11.
Rossmann, Eva, Rodiça Lenkei, Jeanette Lundin, Håkan Mellstedt, & Anders Österborg. (2007). Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia. Cytometry Part B Clinical Cytometry. 72B(6). 450–457. 24 indexed citations
12.
Rossmann, Eva, Annelie Liljegren, & Jonas Bergh. (2007). Male breast cancer – how to treat?. 10(8). 4 indexed citations
13.
Lundin, Jeanette, Anna Porwit‐MacDonald, Eva Rossmann, et al.. (2004). Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia. 18(3). 484–490. 91 indexed citations
14.
Mozaffari, Fariba, Lotta Hansson, Shahryar Kiaii, et al.. (2004). Signalling molecules and cytokine production in T cells of multiple myeloma‐increased abnormalities with advancing stage. British Journal of Haematology. 124(3). 315–324. 63 indexed citations
15.
Ullenhag, Gustav, Jan‐Erik Frödin, Mahmood Jeddi‐Tehrani, et al.. (2004). Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. Clinical Cancer Research. 10(10). 3273–3281. 70 indexed citations
16.
Kiaii, Shahryar, Lotta Hansson, Eva Rossmann, et al.. (2003). Kinetics of Cytokine Gene Expression in Human CD4+ and CD8+ T‐Lymphocyte Subsets Using Quantitative Real‐Time PCR. Scandinavian Journal of Immunology. 58(6). 601–606. 43 indexed citations
17.
Rossmann, Eva, Nongnit Lewin, Mahmood Jeddi‐Tehrani, Anders Österborg, & Håkan Mellstedt. (2002). Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B‐CLL). European Journal Of Haematology. 68(5). 299–306. 45 indexed citations
18.
Rossmann, Eva, Jeanette Lundin, Rodiça Lenkei, Håkan Mellstedt, & Anders Österborg. (2001). Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. The Hematology Journal. 2(5). 300–306. 60 indexed citations
19.
Laytragoon‐Lewin, Nongnit, Eva Rossmann, Juan Castro, & Håkan Mellstedt. (2001). Significance of phosphotyrosine proteins, Bcl‐2 and p53 for apoptosis in resting b‐chronic lymphocytic leukemia (CLL) cells. International Journal of Cancer. 97(3). 344–348. 8 indexed citations
20.
Kretschmer, G., Eva Rossmann, M. Schemper, et al.. (1991). [Acetylsalicylic acid after iliac-femoro-popliteal interventions?].. PubMed. 57(4). 649–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Poiret Breakdown of academic impact, for papers by Lalit Rane Breakdown of academic impact, for papers by Julia Carnevale Breakdown of academic impact, for papers by Christopher Allen Breakdown of academic impact, for papers by Shai Rosenberg Breakdown of academic impact, for papers by Tim Sauer Breakdown of academic impact, for papers by Christine M. Coquery Breakdown of academic impact, for papers by Svetlana M. Mazel Breakdown of academic impact, for papers by Maria R. Fischette Breakdown of academic impact, for papers by Stefanie Schmidt
Rankless by CCL
2026